RC
RA CAPITAL MANAGEMENT, L.P.
BOSTON MA · SEC CIK 0001346824
$11.51B2026Q2 reported value
84Positions
60.4%Top 10 weight · largest 23.8%
11 / 17New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
ABVX New+$150.92M
ORKA New+$147.95M
ARTV Added+$78.59M
NTLA New+$76.60M
DFTX New+$70.56M
2026Q2 top sells estimated at quarter-end value
DNTH Sold out-$219.18M
NUVALENT INC-A Reduced-$159.03M
PRAX Sold out-$120.43M
SRPT Sold out-$84.92M
EWTX Reduced-$82.71M
2026Q2 holdings click a header to sort · 100 rows per page
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A/S | $2.74B | 23.83% | 10,281,496 | 0 | 0.0% | — | Unchanged |
| PBLS | PARABILIS MEDICINES INC | $791.91M | 6.88% | 28,933,371 | 28,933,371 | — | — | First reported |
| RYTM | RHYTHM PHARMACEUTICALS INC | $740.22M | 6.43% | 6,666,837 | 0 | 0.0% | — | Unchanged |
| PCVX | VAXCYTE INC | $667.02M | 5.80% | 11,474,599 | 0 | 0.0% | — | Unchanged |
| SION | SIONNA THERAPEUTICS INC | $435.72M | 3.79% | 9,905,045 | 0 | 0.0% | — | Unchanged |
| TYRA | TYRA BIOSCIENCES INC | $389.62M | 3.39% | 12,198,625 | 0 | 0.0% | — | Unchanged |
| EWTX | EDGEWISE THERAPEUTICS INC | $341.00M | 2.96% | 8,392,730 | -2,035,707 | -19.5% | -$82.71M | Reduced |
| NAMS | NEWAMSTERDAM PHARMA CO NV | $323.66M | 2.81% | 9,550,191 | 0 | 0.0% | — | Unchanged |
| COAG | HEMAB THERAPEUTICS HOLDINGS | $286.81M | 2.49% | 7,808,627 | 7,808,627 | — | — | First reported |
| SEPN | SEPTERNA INC | $234.29M | 2.04% | 6,995,858 | 0 | 0.0% | — | Unchanged |
| BCAX | BICARA THERAPEUTICS INC | $215.43M | 1.87% | 7,255,993 | 0 | 0.0% | — | Unchanged |
| MLYS | MINERALYS THERAPEUTICS INC | $207.55M | 1.80% | 7,692,750 | 0 | 0.0% | — | Unchanged |
| GHRS | GH RESEARCH PLC | $205.28M | 1.78% | 7,636,813 | -39,884 | -0.5% | -$1.07M | Reduced |
| IRON | DISC MEDICINE INC | $179.21M | 1.56% | 2,450,221 | 0 | 0.0% | — | Unchanged |
| SGP | SPYGLASS PHARMA INC | $178.55M | 1.55% | 8,021,117 | 0 | 0.0% | — | Unchanged |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | $174.17M | 1.51% | 17,955,642 | 8,102,340 | 82.2% | $78.59M | Added |
| JANX | JANUX THERAPEUTICS INC | $171.87M | 1.49% | 11,189,693 | 0 | 0.0% | — | Unchanged |
| TSHA | TAYSHA GENE THERAPIES INC | $160.41M | 1.39% | 23,555,648 | 0 | 0.0% | — | Unchanged |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $158.27M | 1.38% | 15,827,186 | 0 | 0.0% | — | Unchanged |
| WVE | WAVE LIFE SCIENCES LTD | $156.73M | 1.36% | 26,975,505 | 0 | 0.0% | — | Unchanged |
| — | NUVALENT INC-A | $153.94M | 1.34% | 1,246,456 | -1,287,689 | -50.8% | -$159.03M | Reduced |
| ABVX | ABIVAX SA-ADR | $150.92M | 1.31% | 1,132,557 | 1,132,557 | — | $150.92M | New |
| ORKA | ORUKA THERAPEUTICS INC | $147.95M | 1.29% | 1,554,597 | 1,554,597 | — | $147.95M | New |
| CLYM | CLIMB BIO INC | $147.36M | 1.28% | 11,300,939 | 0 | 0.0% | — | Unchanged |
| SLDB | SOLID BIOSCIENCES INC | $120.24M | 1.04% | 12,036,126 | 2,696,148 | 28.9% | $26.93M | Added |
| ZLAB | ZAI LAB LTD-ADR | $109.13M | 0.95% | 5,743,533 | 36,271 | 0.6% | $689,149 | Added |
| SPRY | ARS PHARMACEUTICALS INC | $87.00M | 0.76% | 10,860,977 | 0 | 0.0% | — | Unchanged |
| XNCR | XENCOR INC | $84.92M | 0.74% | 5,274,274 | 377,037 | 7.7% | $6.07M | Added |
| JBIO | JADE BIOSCIENCES INC | $81.57M | 0.71% | 3,671,083 | 0 | 0.0% | — | Unchanged |
| NTLA | INTELLIA THERAPEUTICS INC | $76.60M | 0.67% | 4,526,926 | 4,526,926 | — | $76.60M | New |
| LBRX | LB PHARMACEUTICALS INC | $71.68M | 0.62% | 2,208,604 | 0 | 0.0% | — | Unchanged |
| DFTX | DEFINIUM THERAPEUTICS INC | $70.56M | 0.61% | 1,500,000 | 1,500,000 | — | $70.56M | New |
| ACRS | ACLARIS THERAPEUTICS INC | $67.30M | 0.58% | 12,723,026 | 5,918,954 | 87.0% | $31.31M | Added |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $67.16M | 0.58% | 5,049,779 | 0 | 0.0% | — | Unchanged |
| SANA | SANA BIOTECHNOLOGY INC | $65.44M | 0.57% | 18,750,000 | 18,750,000 | — | $65.44M | New |
| DMRA | DAMORA THERAPEUTICS INC | $62.42M | 0.54% | 2,399,702 | 392 | 0.0% | $10,196 | Added |
| MNPR | MONOPAR THERAPEUTICS INC | $61.78M | 0.54% | 667,207 | 0 | 0.0% | — | Unchanged |
| — | ACUMEN PHARMACEUTICALS INC | $56.05M | 0.49% | 20,992,669 | 0 | 0.0% | — | Unchanged |
| GERN | GERON CORP | $54.80M | 0.48% | 42,809,751 | -20,961,615 | -32.9% | -$26.83M | Reduced |
| RZLT | REZOLUTE INC | $49.11M | 0.43% | 9,445,039 | 265,039 | 2.9% | $1.38M | Added |
| EVMN | EVOMMUNE INC | $46.44M | 0.40% | 3,494,638 | 0 | 0.0% | — | Unchanged |
| VOR | VOR BIOPHARMA INC | $44.22M | 0.38% | 2,402,095 | -3,002,903 | -55.6% | -$55.28M | Reduced |
| IPSC | CENTURY THERAPEUTICS INC | $43.50M | 0.38% | 17,754,430 | 0 | 0.0% | — | Unchanged |
| AKTS | AKTIS ONCOLOGY INC | $42.36M | 0.37% | 1,314,405 | -188,679 | -12.6% | -$6.08M | Reduced |
| BIOA | BIOAGE LABS INC | $40.97M | 0.36% | 1,671,648 | 21,000 | 1.3% | $514,710 | Added |
| CCCC | C4 THERAPEUTICS INC | $37.36M | 0.32% | 8,000,000 | 0 | 0.0% | — | Unchanged |
| MIRM | MIRUM PHARMACEUTICALS INC | $37.29M | 0.32% | 318,554 | 0 | 0.0% | — | Unchanged |
| CAPR | CAPRICOR THERAPEUTICS INC | $36.31M | 0.32% | 1,507,844 | 0 | 0.0% | — | Unchanged |
| — | PEPGEN INC | $36.12M | 0.31% | 20,064,545 | 0 | 0.0% | — | Unchanged |
| PRLD | PRELUDE THERAPEUTICS INC | $34.52M | 0.30% | 6,475,882 | 6,475,882 | — | $34.52M | New |
| NKTX | NKARTA INC | $30.58M | 0.27% | 10,805,129 | 0 | 0.0% | — | Unchanged |
| QTTB | Q32 BIO INC | $29.72M | 0.26% | 2,332,457 | 2,332,457 | — | $29.72M | New |
| AVR | ANTERIS TECHNOLOGIES GLOBAL | $29.55M | 0.26% | 3,000,000 | 0 | 0.0% | — | Unchanged |
| EDIT | EDITAS MEDICINE INC | $28.80M | 0.25% | 8,889,000 | 8,889,000 | — | $28.80M | New |
| OVID | OVID THERAPEUTICS INC | $28.25M | 0.25% | 10,500,968 | -213,032 | -2.0% | -$573,056 | Reduced |
| ASMB | ASSEMBLY BIOSCIENCES INC | $28.04M | 0.24% | 1,020,410 | 0 | 0.0% | — | Unchanged |
| ALXO | ALX ONCOLOGY HOLDINGS INC | $26.93M | 0.23% | 13,011,849 | 0 | 0.0% | — | Unchanged |
| BNTC | BENITEC BIOPHARMA INC | $24.75M | 0.22% | 1,850,000 | 0 | 0.0% | — | Unchanged |
| LENZ | LENZ THERAPEUTICS INC | $23.74M | 0.21% | 4,178,823 | 0 | 0.0% | — | Unchanged |
| LXEO | LEXEO THERAPEUTICS INC | $23.27M | 0.20% | 5,000,000 | 0 | 0.0% | — | Unchanged |
| — | ACRIVON THERAPEUTICS INC | $21.77M | 0.19% | 12,229,396 | 3,888,888 | 46.6% | $6.92M | Added |
| ALT | ALTIMMUNE INC | $19.76M | 0.17% | 6,500,000 | 6,500,000 | — | $19.76M | New |
| KPTI | KARYOPHARM THERAPEUTICS INC | $18.73M | 0.16% | 1,917,354 | 0 | 0.0% | — | Unchanged |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | $18.60M | 0.16% | 265,000 | 0 | 0.0% | — | Unchanged |
| AVTX | AVALO THERAPEUTICS INC | $18.48M | 0.16% | 1,000,000 | 337,032 | 50.8% | $6.23M | Added |
| OKUR | ONKURE THERAPEUTICS INC-A | $18.23M | 0.16% | 3,998,333 | 0 | 0.0% | — | Unchanged |
| FTH | FAETH THERAPEUTICS INC | $18.05M | 0.16% | 722,020 | 722,020 | — | $18.05M | New |
| AURA | AURA BIOSCIENCES INC | $17.75M | 0.15% | 2,500,000 | 2,500,000 | — | $17.75M | New |
| SABS | SAB BIOTHERAPEUTICS INC | $17.17M | 0.15% | 4,401,500 | 0 | 0.0% | — | Unchanged |
| SPTX | SEAPORT THERAPEUTICS INC | $15.20M | 0.13% | 700,000 | 700,000 | — | — | First reported |
| PALI | PALISADE BIO INC | $14.89M | 0.13% | 7,124,116 | 0 | 0.0% | — | Unchanged |
| HLXC | HELIX ACQUISITION CORP-CL A | $13.30M | 0.12% | 1,250,000 | 0 | 0.0% | — | Unchanged |
| WAY | WAYSTAR HOLDING CORP | $10.87M | 0.09% | 529,400 | 0 | 0.0% | — | Unchanged |
| EQ | EQUILLIUM INC | $9.91M | 0.09% | 3,096,336 | 0 | 0.0% | — | Unchanged |
| MGNX | MACROGENICS INC | $8.61M | 0.07% | 1,864,176 | 0 | 0.0% | — | Unchanged |
| — | PERCEPTIVE CAPITAL SOLUTIONS | $8.16M | 0.07% | 750,000 | 0 | 0.0% | — | Unchanged |
| — | ADICET BIO INC | $8.06M | 0.07% | 932,624 | -250,000 | -21.1% | -$2.16M | Reduced |
| — | NEWAMSTERDAM PHARMA CO NV-27 | $7.12M | 0.06% | 333,333 | 0 | 0.0% | — | Unchanged |
| CRVS | CORVUS PHARMACEUTICALS INC | $6.72M | 0.06% | 450,000 | 0 | 0.0% | — | Unchanged |
| — | RANI THERAPEUTICS HOLDINGS-A | $6.46M | 0.06% | 8,500,000 | 0 | 0.0% | — | Unchanged |
| — | JATT II ACQUISITION CORP | $5.68M | 0.05% | 500,000 | 500,000 | — | — | First reported |
| — | AMANAT ACQUISITION CORP CL A | $3.81M | 0.03% | 375,000 | 375,000 | — | — | First reported |
| — | WEREWOLF THERAPEUTICS INC | $859,349 | 0.01% | 2,387,744 | -4,293,563 | -64.3% | -$1.55M | Reduced |
| — | PALATIN TECHNOLOGIES INC | $670,318 | 0.01% | 62,124 | -7,876 | -11.3% | -$84,982 | Reduced |
| DNTH | DIANTHUS THERAPEUTICS INC | $0 | 0.00% | 0 | -2,611,733 | -100.0% | -$219.18M | Sold out |
| PRAX | PRAXIS PRECISION MEDICINES I | $0 | 0.00% | 0 | -373,787 | -100.0% | -$120.43M | Sold out |
| SRPT | SAREPTA THERAPEUTICS INC | $0 | 0.00% | 0 | -3,902,596 | -100.0% | -$84.92M | Sold out |
| SYRE | SPYRE THERAPEUTICS INC | $0 | 0.00% | 0 | -1,621,620 | -100.0% | -$81.79M | Sold out |
| FULC | FULCRUM THERAPEUTICS INC | $0 | 0.00% | 0 | -6,053,960 | -100.0% | -$46.43M | Sold out |
| OLMA | OLEMA PHARMACEUTICALS INC | $0 | 0.00% | 0 | -2,600,000 | -100.0% | -$38.77M | Sold out |
| DSGN | DESIGN THERAPEUTICS INC | $0 | 0.00% | 0 | -2,972,973 | -100.0% | -$31.63M | Sold out |
| TVTX | TRAVERE THERAPEUTICS INC | $0 | 0.00% | 0 | -746,841 | -100.0% | -$22.19M | Sold out |
| GRAL | GRAIL INC | $0 | 0.00% | 0 | -428,266 | -100.0% | -$22.13M | Sold out |
| RLMD | RELMADA THERAPEUTICS INC | $0 | 0.00% | 0 | -2,947,369 | -100.0% | -$20.51M | Sold out |
| STRO | SUTRO BIOPHARMA INC | $0 | 0.00% | 0 | -715,307 | -100.0% | -$17.82M | Sold out |
| CTNM | CONTINEUM THERAPEUTICS INC-A | $0 | 0.00% | 0 | -1,296,012 | -100.0% | -$16.93M | Sold out |
| INSP | INSPIRE MEDICAL SYSTEMS INC | $0 | 0.00% | 0 | -325,663 | -100.0% | -$16.80M | Sold out |
| HNGE | HINGE HEALTH INC-A | $0 | 0.00% | 0 | -364,613 | -100.0% | -$14.06M | Sold out |
| WGS | GENEDX HOLDINGS CORP | $0 | 0.00% | 0 | -209,887 | -100.0% | -$13.48M | Sold out |
| RNA | ATRIUM THERAPEUTICS INC | $0 | 0.00% | 0 | -864,102 | -100.0% | -$11.55M | Sold out |